Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the third quarter of 2014.
Non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the third quarter of $0.90 exclude acquisition- and divestiture-related costs, restructuring costs and certain other items.
Help employers find you! Check out all the jobs and post your resume.
